MPD: List measures where strain SJL/J is an outlier

List measures where SJL/J is an outlier

Click on pulldowns below to see SJL/J means with summary statistic tooltips.
Within each pulldown, the "up" and "down" triangles indicate when this strain is an outlier.
You can also download all phenotypes for this strain and sort by Z score in Excel.

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Berndt2:61	Berndt2	plethysmography	methacholine	enhanced pause penh 35161 saline 5 MCh 10 MCh 20 MCh response index	inbred	29	both	9-12wks	N=8	2010

Berndt2:68	Berndt2	plethysmography	methacholine	tidal volume [mL] tidal_vol 35168 saline 5 MCh 10 MCh 20 MCh response index	inbred	29	both	9-12wks	N=8	2010

Bodnar1:20	Bodnar1	intake monitoring	sucrose	daily water intake with sucrose in drinking water [mL] water 22620 baseline 0.01% 2.5% 20%	inbred	12	m	13-17wks	N=10	2006

Brown1:30	Brown1	elevated zero maze	(none)	closed zone entries [n] close_ent_EZM 9430	inbred	13	both	10wks	N=9	2004

Brown1:60	Brown1	elevated zero maze	(none)	open zone entries [n] open_ent_EZM 9460	inbred	13	both	10wks	N=9	2004

Crabbe2:4	Crabbe2	monitoring system	diazepam	horizontal distance traveled, immediately to 15 min post-injection [cm] horiz_DZ 15504 baseline doses mg/kg: 2 4 8 16	inbred	15	m	6-7wks	N=8	1998

Graubert1:3	Graubert1	complete blood count	(none)	lymphocyte count (LYMP; units per volume x 10³) [n/µL] LYMP 11603	inbred	20	both	9wks	N=12	2006

Graubert1:5	Graubert1	complete blood count	(none)	lymphocyte differential (LYM; percentage of total WBC) [%] pct_LYMP 11605	inbred	20	both	9wks	N=12	2006

Harrill1:13	Harrill1	organ weights	isoniazid	spleen weight as percentage of body weight [%] pct_spleen 39513 control isoniazid	inbred	34	f	8-10wks	N=4	2011

Harrill2:25	Harrill2	urinalysis	DB289	urine volume [mL] urine_vol 44125 control DB289 difference	inbred	33	f	6-8wks	N=5	2012

Harrill2:35	Harrill2	biomarker quantification	DB289	urine kidney injury molecule 1 (KIM-1) [pg] urine_KIM1 44135 control DB289 difference	inbred	33	f	6-8wks	N=4	2012

Hawes1:12	Hawes1	slit lamp	(none)	iris coloboma [frequency rate] iris_coloboma 26712	inbred w/CC7	41	both	6-7wks	N=10	2008

Jaxwest1:5	Jaxwest1	ECG	(none)	interval between peak of Q-wave to end of T-wave (QT) [ms] QT 15105	inbred	7	both	8-10wks	N=8	2003

Jaxwest1:6	Jaxwest1	ECG	(none)	rate-corrected QT interval [ms] QTc 15106	inbred	7	both	8-10wks	N=8	2003

Jaxwest1:10	Jaxwest1	tail cuff	(none)	heart rate coefficient of variance [%] HR_cv 15110	inbred	7	both	8-10wks	N=8	2003

Justice2:4	Justice2	complete blood count	(none)	white blood cell count (WBC; per volume x 10³) [n/µL] WBC 13204	inbred	16	both	12-16wks	N=12	2002

Justice2:12	Justice2	complete blood count	(none)	mean platelet volume (MPV) [fL] MPV 13212	inbred	16	both	12-16wks	N=12	2002

Korstanje1:1	Korstanje1	urinalysis	(none)	microalbumin (urine MA) [mg/dL] MA 29701 12mo 18mo 24mo	inbred	30	both		N=7	2008

Korstanje1:21	Korstanje1	urinalysis	(none)	albumin-creatinine ratio (urine ACR) [mg/g] ACR 29721 12mo 18mo 24mo	inbred	30	both		N=7	2008

Kumar3:19	Kumar3	open field test	(none)	time spent grooming first 5 min [s] GrTime5m 112927	inbred w/CC8	62	both	8-14wks	N=20	2021

Kumar3:20	Kumar3	open field test	(none)	time spent grooming first 20 min [s] GrTime20m 112928	inbred w/CC8	62	both	8-14wks	N=20	2021

Kumar3:21	Kumar3	open field test	(none)	time spent grooming first 55 min [s] GrTime55m 112929	inbred w/CC8	62	both	8-14wks	N=20	2021

Kumar3:22	Kumar3	open field test	(none)	time spent grooming in first 55 min divided by 55 [] GrTimeSlope55m 112930	inbred w/CC8	62	both	8-14wks	N=20	2021

Kumar3:23	Kumar3	open field test	(none)	number of grooming events in first 5 min [n] GrBoutNum5m 112931	inbred w/CC8	62	both	8-14wks	N=20	2021

Kumar3:24	Kumar3	open field test	(none)	number of grooming events in first 20 min [n] GrBoutNum20m 112932	inbred w/CC8	62	both	8-14wks	N=20	2021

Kumar3:26	Kumar3	open field test	(none)	number of grooming events first 55 min divided by 55 [n/min] GrBoutNumSlope55m 112934	inbred w/CC8	62	both	8-14wks	N=20	2021

Kumar3:27	Kumar3	open field test	(none)	duration of grooming events first 5 min (s per event) [s/n] GrBoutLength5m 112935	inbred w/CC8	62	both	8-14wks	N=15	2021

Kumar3:28	Kumar3	open field test	(none)	duration of grooming events first 20 min (s per event) [s/n] GrBoutLength20m 112936	inbred w/CC8	62	both	8-14wks	N=19	2021

Kumar3:31	Kumar3	open field test	(none)	time when animal grooms most during 55 min test [min] GrPeakMidBin 113847	inbred w/CC8	62	both	8-14wks	N=20	2021

Kumar3:32	Kumar3	open field test	(none)	amount of time spent grooming when animal grooms most (in 5 min range) [s] GrPeakVal 113848	inbred w/CC8	62	both	8-14wks	N=20	2021

Kumar3:33	Kumar3	open field test	(none)	amount of time spent grooming when animal grooms most divided by time when animal grooms most during first 55 min GrPeakSlope 113849	inbred w/CC8	62	both	8-14wks	N=20	2021

Kumar4:5	Kumar4	gait analysis	(none)	angular velocity over duration of stride, mean [deg/s] angular_velocity_mean 114435	inbred w/CC8	62	both	10-20wks	N=19	2021

Kumar4:6	Kumar4	gait analysis	(none)	angular velocity over duration of stride, median [deg/s] angular_velocity_median 114436	inbred w/CC8	62	both	10-20wks	N=19	2021

Kumar4:11	Kumar4	gait analysis	(none)	limb duty factor, hind paws (keypoints), mean limb_duty_factor_mean 114441	inbred w/CC8	62	both	10-20wks	N=19	2021

Lightfoot1:3	Lightfoot1	running wheel monitoring	(none)	wheel running activity, mean speed [m/min] activity_speed 35703	inbred	41	both	8-16wks	N=6	2010

Maurer1:1	Maurer1	tail cuff	atenolol, isoproterenol	pulse rate [n/min] pulse 33201 control atenolol 10mg isoprot 1mg isoprot 10mg	inbred	23	m	7-13wks	N=11	2009

Maurer1:9	Maurer1	tail cuff	atenolol, isoproterenol	systolic blood pressure [mmHg] BP 33209 control atenolol 10mg isoprot 1mg isoprot 10mg	inbred	23	m	7-13wks	N=10	2009

Maurer1:45	Maurer1	ECG	atenolol, isoproterenol	interval QT [ms] QT 33245 control atenolol 10mg isoprot 1mg isoprot 10mg	inbred	23	m	7-13wks	N=10	2009

Maurer1:49	Maurer1	ECG	atenolol, isoproterenol	interval ST [ms] ST 33249 control atenolol 10mg isoprot 1mg isoprot 10mg	inbred	23	m	7-13wks	N=10	2009

Maurer1:61	Maurer1	ECG	atenolol, isoproterenol	area of QTc [ms*mV] QTc_area 33261 control atenolol 10mg isoprot 1mg isoprot 10mg	inbred	23	m	7-13wks	N=10	2009

Mills1:35	Mills1	chromosome instability assessment	(none)	non-nucleated peripheral blood cells with micronuclei [%] all_micronucl 25235 6mo 12mo 20mo	inbred	30	both		N=5	2008

Moy1:8	Moy1	three chamber assay	(none)	time spent in chamber with stranger1 (former novel mouse), 10 min test [s] DurSTR1_nov 30108	inbred	17	m	6-7wks	N=22	2008

Peters1:7	Peters1	complete blood count	(none)	mean RBC corpuscular hemoglobin concentration (MCHC) [g/dL] MCHC 6207	inbred w/CC7	43	both	10wks	N=12	2001

Peters1:14	Peters1	complete blood count	(none)	eosinophil differential (percent of total WBC) [%] EOS 6214	inbred w/CC7	43	both	10wks	N=11	2001

Peters4:21	Peters4	complete blood count	(none)	eosinophil count (EOS; units per volume x 10³) [n/µL] EOS 24321 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:29	Peters4	complete blood count	(none)	large unstained cells count (LUC; units per volume x 10³) [n/µL] LUC 24329 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:45	Peters4	complete blood count	(none)	eosinophil differential (EOS; percentage of total WBC) [%] pctEOS 24345 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:53	Peters4	complete blood count	(none)	large unstained cells differential (LUC; percentage of total WBC) [%] pctLUC 24353 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:69	Peters4	complete blood count	(none)	mean RBC hemoglobin concentration (MCHC) [g/dL] MCHC 24369 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:81	Peters4	complete blood count	(none)	reticulocyte differential [%] pctRetic 24381 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Petkova1:29	Petkova1	immune cell quantification	(none)	CD4 T cells, as percentage of total lymphocytes [%] CD4_all 24229 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Petkova1:37	Petkova1	immune cell quantification	(none)	CD4 T cells, central memory, as percentage of total CD4 T cells [%] CD4_mem_central 24237 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Tordoff1:3	Tordoff1	bottle choice test	(none)	preference for NaCl (sodium chloride) solutions [%] NaCl_pref 6103 concentration (mM): 75 150 300 450	inbred	28	m	4-12wks	N=11	2001

Wahlsten1:51	Wahlsten1	elevated plus maze	(none)	number fecal boli, 5 min trial [n] defecation_EPM 10851	inbred	21	both	9wks	N=9	2003

Wiltshire4:7	Wiltshire4	immune cell quantification	BEZ235	T cells, percent viability [%] Tcells_BEZ 52407 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	34	m	10wks	N=4	2015

Wiltshire4:21	Wiltshire4	immune cell quantification	doxorubicin	B cells, percent viability [%] Bcells_Dox 52421 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	35	m	10wks	N=4	2015

Wiltshire4:33	Wiltshire4	immune cell quantification	doxorubicin	monocytes, percent viability [%] monocytes_Dox 52433 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	35	m	10wks	N=4	2015

Wiltshire4:61	Wiltshire4	immune cell quantification	selumetinib	B cells, percent viability [%] Bcells_Sel 52461 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	34	m	10wks	N=4	2015

Xing1:31	Xing1	ECG	(none)	interval QT [ms] QT 24931 6mo 12mo 20mo	inbred	29	both		N=7	2008

Xing1:41	Xing1	ECG	(none)	interval ST [ms] ST 24941 6mo 12mo 20mo	inbred	29	both		N=7	2008

List measures where SJL/J is an outlier

Filter Table Results